GeneDx Holdings Corp. (WGS)

SEC filing

GeneDx Holdings Corp.

WGS · CIK 1818331

4 · May 1, 2026 · Stueland Katherine sold 2,172 shares at $65.19/share ($141.6K); exercised options for 3,874 shares

Stueland Katherine sold 2,172 shares at $65.19/share ($141.6K); exercised options for 3,874 shares

xslF345X06/form4-05012026_080508.xml

xslF345X06/form4-05012026_080508.xmlSEC.gov

Graphics and non-inline formats (not embedded below).